Stock Split History
ETFs Holding ARDS »    ARDS Historical Stock Prices »
Video: What is a Stock Split?

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Aridis Pharmaceuticals is a late-stage biopharmaceutical company focused on the discovery and development of targeted immunotherapy using human monoclonal antibodies (mAbs) to treat infections. Co.'s product candidates include: AR-301, which is a human immunoglobulin 1 (IgG1) mAb targeting the gram-positive bacteria S. aureus alphatoxin; AR-320, which is a human, IgG1 monoclonal antibody targeting S. aureus alpha toxin; AR-501 (Panaecin), which is a spectrum small molecule anti-infective Co. is developing in addition to its targeted mAb product candidates; and AR-101, which is a human immunoglobulin M mAb targeting the gram-negative bacteria P. aeruginosa serotype O11. According to our Aridis Pharmaceuticals stock split history records, Aridis Pharmaceuticals has had 0 splits.
Aridis Pharmaceuticals stock split history picture
Aridis Pharmaceuticals (ARDS) has 0 splits in our Aridis Pharmaceuticals stock split history database.

Looking at the Aridis Pharmaceuticals stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Aridis Pharmaceuticals shares, starting with a $10,000 purchase of ARDS, presented on a split-history-adjusted basis factoring in the complete Aridis Pharmaceuticals stock split history. Aridis Pharmaceuticals split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 08/15/2018
End date: 09/23/2022
Start price/share: $12.96
End price/share: $1.21
Dividends collected/share: $0.00
Total return: -90.66%
Average Annual Total Return: -43.84%
Starting investment: $10,000.00
Ending investment: $933.79
Years: 4.11
Date Ratio
Annaly Capital Management, Inc. (NLY)
CohBar, Inc. (CWBR)
TOP Ships Inc. (TOPS)
Sonnet BioTherapeutics Holdings, Inc. (SONN)
Nabriva Therapeutics plc (NBRV)
NeuroBo Pharmaceuticals, Inc. (NRBO)
First Wave BioPharma, Inc. (FWBI)
Palatin Technologies, Inc. (PTIN)
TD Holdings, Inc. (GLG )
Iterum Therapeutics plc (ITRM)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »
Funds Holding Aridis Pharmaceuticals
Aridis Pharmaceuticals Insider Buying

Aridis Pharmaceuticals Stock Split History | | Copyright © 2013 - 2022, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.